Cargando…
DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
Lung, breast, colorectal, and prostate cancers are the most incident worldwide. Optimal population-based cancer screening methods remain an unmet need, since cancer detection at early stages increases the prospects of successful and curative treatment, leading to a lower incidence of recurrences. Mo...
Autores principales: | Constâncio, Vera, Nunes, Sandra P., Henrique, Rui, Jerónimo, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140532/ https://www.ncbi.nlm.nih.gov/pubmed/32150897 http://dx.doi.org/10.3390/cells9030624 |
Ejemplares similares
-
Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel
por: Constâncio, Vera, et al.
Publicado: (2019) -
Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies
por: Nunes, Sandra P., et al.
Publicado: (2019) -
Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients
por: Moreira-Barbosa, Catarina, et al.
Publicado: (2018) -
Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances
por: Lourenço, Catarina, et al.
Publicado: (2021) -
DNA methylation biomarkers accurately detect esophageal cancer prior and post neoadjuvant chemoradiation
por: Macedo‐Silva, Catarina, et al.
Publicado: (2023)